Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.93
+0.36 (3.76%)
At close: Jun 18, 2026, 4:00 PM EDT
9.92
-0.01 (-0.10%)
After-hours: Jun 18, 2026, 5:45 PM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $881.53 million as of June 18, 2026. Its market cap has increased by 57.87% in one year.
Market Cap
881.53M
Enterprise Value
324.98M
1-Year Change
57.87%
Ranking
Category
Stock Price
$9.93
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $881.53M, an increase of 675.31%. That is a compound annual growth rate of 21.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 881.50M | -2.50% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 915.32M |
| Odyssey Therapeutics | 899.61M |
| Arbutus Biopharma | 898.80M |
| Lexicon Pharmaceuticals | 892.83M |
| Alpha Tau Medical | 881.92M |
| ORIC Pharmaceuticals | 878.86M |
| Janux Therapeutics | 867.20M |
| Phathom Pharmaceuticals | 864.20M |